AMRS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 bal. 2024 @ 23:00):

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America...

Stats
Šios dienos apimtis	46.75M
Vidutinė apimtis	0.00
Rinkos kapitalizacija	18.47M
EPS	$0 ( 2024-03-13 )
Kita pelno data	( $0 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0400
ATR14	$0.0800 (181.00%)

Insider Trading

Date	Person	Action	type
2023-08-29	White J. Scott	Buy
2023-08-09	Gund Philip J.	Buy
2023-08-09	Reiss M. Freddie	Buy
2023-06-05	Doerr L John	Sell	2019 LSA
2023-06-05	Doerr L John	Buy	2019 LSA

INSIDER POWER
76.13
Last 91 transactions
Buy: 37 820 332 \| Sell: 7 047 762

Tūris Koreliacija

Ilgas: -0.25 (neutral)

Trumpas: 0.66 (moderate)

Signal:(25.624) Neutral

Amyris Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
RMRM	0.955
CMBM	0.924
YTRA	0.922
SONM	0.914
SPRB	0.911
PLL	0.909
HAS	0.904
HLIT	0.901
SILC	0.9
ANIK	0.899

10 Labiausiai neigiamai susiję koreliacijos
PCTI	-0.954
CTIC	-0.954
ERIE	-0.945
GECC	-0.927
ALR	-0.927
CORT	-0.92
OLK	-0.915
IFBD	-0.912
JUPW	-0.907
HARP	-0.905

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Amyris Inc Koreliacija - Valiuta/Žaliavos

-0.12
( neutral )

-0.48
( neutral )

-0.20
( neutral )

-0.25
( neutral )

-0.05
( neutral )

Amyris Inc Finansinės ataskaitos

Annual	2022
Pajamos:	$269.85M
Bruto pelnas:	$11.18M (4.14 %)
EPS:	$-1.580

FY	2022
Pajamos:	$269.85M
Bruto pelnas:	$11.18M (4.14 %)
EPS:	$-1.580

FY	2021
Pajamos:	$341.82M
Bruto pelnas:	$186.68M (54.61 %)
EPS:	$-0.930

FY	2020
Pajamos:	$173.14M
Bruto pelnas:	$85.33M (49.28 %)
EPS:	$-1.880

Financial Reports:

No articles found.

Amyris Inc

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.